Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Seiler

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Agents and Actions|September 1, 1991
15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE)H U Schorlemmer, F R Seiler
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1982
[The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation]H H Sedlacek, F R Seiler
Drugs Under Experimental and Clinical Research|January 1, 1991
Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS)H U Schorlemmer, F R Seiler
Behring Institute Mitteilungen|May 1, 1984
Attempts towards improvement in cancer therapyF R Seiler, H H Sedlacek
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1983
[Prevention and therapy with immunoglobulins: a critical comment on the question of the immune complex-induced inflammatory reaction]H H Sedlacek, F R Seiler
Lancet (London, England)|April 5, 1975
Letter: Treatment of multiple sclerosis with anti-lymphocyte globulinF R Seiler, H G Schwick
Developments in Biological Standardization|April 13, 1977
Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cellsH H Sedlacek, F R Seiler
Behring Institute Mitteilungen|May 1, 1984
Immunotoxins--theoretical and practical aspectsT Hofstaetter, P Gronski, F R Seiler
Behring Institute Mitteilungen|April 1, 1988
Preparation and use of synthetic blood group specific immunoadsorbentsC Kolar, U Knödler, F R Seiler
Behring Institute Mitteilungen|April 1, 1988
Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugsD Krumwieh, G Schulz, F R Seiler
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Agents and Actions|September 1, 1991
15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE)H U Schorlemmer, F R Seiler
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1982
[The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation]H H Sedlacek, F R Seiler
Drugs Under Experimental and Clinical Research|January 1, 1991
Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS)H U Schorlemmer, F R Seiler
Behring Institute Mitteilungen|May 1, 1984
Attempts towards improvement in cancer therapyF R Seiler, H H Sedlacek
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1983
[Prevention and therapy with immunoglobulins: a critical comment on the question of the immune complex-induced inflammatory reaction]H H Sedlacek, F R Seiler
Lancet (London, England)|April 5, 1975
Letter: Treatment of multiple sclerosis with anti-lymphocyte globulinF R Seiler, H G Schwick
Developments in Biological Standardization|April 13, 1977
Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cellsH H Sedlacek, F R Seiler
Behring Institute Mitteilungen|May 1, 1984
Immunotoxins--theoretical and practical aspectsT Hofstaetter, P Gronski, F R Seiler
Behring Institute Mitteilungen|April 1, 1988
Preparation and use of synthetic blood group specific immunoadsorbentsC Kolar, U Knödler, F R Seiler
Behring Institute Mitteilungen|April 1, 1988
Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugsD Krumwieh, G Schulz, F R Seiler
Pageof 12